PS
LABU icon

PayPay Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

PayPay Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Sell
41
-72
-64% -$13.8K 0.29% 52
2026
Q1 		$22.2K Sell
113
-27
-19% -$4.43K 0.77% 35
2025
Q4 		$22.3K Sell
140
-8
-5% -$1.1K 0.65% 32
2025
Q3 		$13.8K Sell
148
-33
-18% -$2.33K 0.5% 31
2025
Q2 		$10.3K Sell
181
-39
-18% -$2.07K 0.5% 34
2025
Q1 		$13.4K Buy
220
+78
+55% +$6.65K 0.77% 30
2024
Q4 		$12.8K Buy
142
+115
+426% +$13.5K 0.55% 35
2024
Q3 		$3.48K Sell
27
-82
-75% -$10.7K 0.31% 72
2024
Q2 		$12.4K Sell
109
-39
-26% -$4.17K 1.03% 18
2024
Q1 		$19.6K Sell
148
-123
-45% -$16.1K 0.98% 19
2023
Q4 		$33K Sell
271
-240
-47% -$18.4K 1.62% 16
2023
Q3 		$39K Buy
511
+34
+7% +$3.49K 1.78% 13
2023
Q2 		$56.5K Buy
477
+308
+182% +$38.4K 3.47% 11
2023
Q1 		$16.6K Buy
+169
New +$22.9K 1.11% 16

Other funds holding LABU

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

PayPay Securities's LABU Position: Q2 2026 in Review

PayPay Securities reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 64% in Q2 2026, selling an estimated $13.8K and leaving 41 shares worth $12K. The position accounts for 0.29% of the portfolio, ranked #52.

PayPay Securities first reported a position in LABU in Q1 2023 and has held it in 14 quarters since. The position peaked at $56.5K in Q2 2023. 6 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • PayPay Securities held 41 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $12K as of Q2 2026.
  • PayPay Securities sold 72 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $13.8K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.29% of PayPay Securities's portfolio in Q2 2026, its #52 holding.
  • PayPay Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and has held it in 14 quarters since.
  • PayPay Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $56.5K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.